Nichi-Iko Pharmaceutical Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nichi-Iko Pharmaceutical Co., Ltd. - overview
Established
1965
Location
Toyama, Toyama, Japan
Primary Industry
Pharmaceuticals
About
Established in 1965 and based in Toyama, Japan, Nichi-Iko Pharmaceutical Co Ltd engages in the research, development, manufacture, and sale of pharmaceutical drugs.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.nichiiko.co.jp
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Nichi-Iko Pharmaceutical Co., Ltd. - timeline of key events
Nichi-Iko Pharmaceutical Co., Ltd. - financials
| Fiscal Year Ended | Mar 31, 2012 | Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 26,998,799,000 | 93,926,056,000 | 103,622,000,000 | 127,021,000,000 | 143,513,000,000 | 163,372,000,000 | 164,717,000,000 | 166,592,000,000 | 190,076,000,000 | - | - | - |
| % Revenue Growth (YoY) | - | 247.9% | 10.3% | 22.6% | 13.0% | 13.8% | 0.8% | 1.1% | 14.1% | - | - | - |
| EBITDA (USD) | 3,651,735,000 | 13,004,830,000 | 13,406,000,000 | 14,613,000,000 | 18,265,000,000 | 15,956,000,000 | 18,960,000,000 | 17,624,000,000 | 14,744,000,000 | - | - | - |
| Operating Income (USD) | 2,139,612,000 | 8,229,243,000 | 7,383,000,000 | 9,619,000,000 | 12,910,000,000 | 8,554,000,000 | 10,301,000,000 | 8,223,000,000 | 2,873,000,000 | - | - | - |
| Operating Margin | 7.9% | 8.8% | 7.1% | 7.6% | 9.0% | 5.2% | 6.3% | 4.9% | 1.5% | - | - | - |
| % EBITDA Margin | 13.5% | 13.8% | 12.9% | 11.5% | 12.7% | 9.8% | 11.5% | 10.6% | 7.8% | - | - | - |
| NET Income (USD) | 1,330,519,000 | 5,129,717,000 | 4,588,000,000 | 6,592,000,000 | 11,031,000,000 | 4,788,000,000 | 8,069,000,000 | 6,864,000,000 | 4,917,000,000 | - | - | - |
| % Net Margin | 4.9% | 5.5% | 4.4% | 5.2% | 7.7% | 2.9% | 4.9% | 4.1% | 2.6% | - | - | - |
Nichi-Iko Pharmaceutical Co., Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PIPE | Announced | Nichi-Iko Pharmaceutical Co., Ltd. | - | ||||||||
| Public to Private | Announced | Nichi-Iko Pharmaceutical Co., Ltd. | - |
Displaying 1 - 2 of 2
Nichi-Iko Pharmaceutical Co., Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.